Propionyl-L-carnitine, L-arginine and niacin in sexual medicine: A nutraceutical approach to erectile dysfunction

Andrologia

Volumn 44, Issue SUPPL.1, 2012, Pages 600-604

  Gianfrilli, D ^a   Lauretta, R ^a   Di Dato, C ^a   Graziadio, C ^a   Pozza, C ^a   De Larichaudy, J ^b   Giannetta, E ^a   Isidori, A M ^a   Lenzi, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Erectile dysfunction; L arginine; Niacin; Nutraceutical; Propionyl L carnitine

Indexed keywords

ARGININE; LEVO ARGININE PLUS NIACIN PLUS PROPRIONYL LEVO CARNITINE; NICOTINIC ACID; NUTRACEUTICAL; PHOSPHODIESTERASE V INHIBITOR; PROPIONYLCARNITINE; UNCLASSIFIED DRUG;

ABDOMINAL DISCOMFORT; ADULT; AGED; ARTICLE; CARDIOVASCULAR SYSTEM; COMORBIDITY; DRUG EFFECT; ERECTILE DYSFUNCTION; FLUSHING; GLOBAL ASSESSMENT QUESTION; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; SEXUALITY; SIDE EFFECT; SINGLE BLIND PROCEDURE; SUPPLEMENTATION; TREATMENT RESPONSE;

ADULT; AGED; ARGININE; CARNITINE; DIETARY SUPPLEMENTS; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; NIACIN;

EID: 84861499134     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/j.1439-0272.2011.01234.x     Document Type: Article

References (23)

1. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A (2003) Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf)58:632-638.
2. Boger RH, Bode-Boger SM, Phivthong-ngam L, Brandes RP, Schwedhelm E, Mugge A, Bohme M, Tsikas D, Frolich JC (1998) Dietary l-arginine and alpha-tocopherol reduce vascular oxidative stress and preserve endothelial function in hypercholesterolemic rabbits via different mechanisms. Atherosclerosis141:31-43.
3. Burnett AL (2004) Novel nitric oxide signaling mechanisms regulate the erectile response. Int J Impot Res16 (Suppl 1): S15-S19.
4. Campese VM, Amar M, Anjali C, Medhat T, Wurgaft A (1997) Effect of l-arginine on systemic and renal haemodynamics in salt-sensitive patients with essential hypertension. J Hum Hypertens11:527-532.
5. Carosa E, Martini P, Brandetti F, Di Stasi SM, Lombardo F, Lenzi A, Jannini EA (2004) Type V phosphodiesterase inhibitor treatments for erectile dysfunction increase testosterone levels. Clin Endocrinol (Oxf)61:382-386.
6. Chen PY, Sanders PW (1991) l-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest88:1559-1567.
7. Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M, Matzkin H (1999) Effect of oral administration of high-dose nitric oxide donor l-arginine in men with organic erectile dysfunction: results of a double-blind, randomized, placebo-controlled study. BJU Int83:269-273.
8. Elliott RB, Pilcher CC, Fergusson DM, Stewart AW (1996) A population based strategy to prevent insulin-dependent diabetes using nicotinamide. J Pediatr Endocrinol Metab9:501-509.
9. Gentile V, Vicini P, Prigiotti G, Koverech A, Di SF (2004) Preliminary observations on the use of propionyl- l-carnitine in combination with sildenafil in patients with erectile dysfunction and diabetes. Curr Med Res Opin20:1377-1384.
10. Gentile V, Antonini G, Antonella BM, Dinelli N, Rizzo C, Ashraf VM, Koverech A (2009) Effect of propionyl- l-carnitine, l-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of erectile dysfunction in diabetes. Curr Med Res Opin 25:2223-2228.
11. Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP (2002) Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Arch Intern Med162:1568-1576.
12. Guyton JR, Blazing MA, Hagar J, Kashyap ML, Knopp RH, McKenney JM, Nash DT, Nash SD (2000) Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group. Arch Intern Med160:1177-1184.
13. Higashi Y, Oshima T, Ozono R, Watanabe M, Matsuura H, Kajiyama G (1995) Effects of l-arginine infusion on renal hemodynamics in patients with mild essential hypertension. Hypertension25 (4 Pt 2): 898-902.
14. Jannini EA, Isidori AM, Gravina GL, Aversa A, Balercia G, Bocchio M, Boscaro M, Carani C, Corona G, Fabbri A, Foresta C, Forti G, Francavilla S, Granata AR, Maggi M, Mansani R, Palego P, Spera G, Vetri M, Lenzi A (2009) The ENDOTRIAL study: a spontaneous, open-label, randomized, multicenter, crossover study on the efficacy of sildenafil, tadalafil, and vardenafil in the treatment of erectile dysfunction. J Sex Med6:2547-2560.
15. Kelsey NA, Wilkins HM, Linseman DA (2010) Nutraceutical antioxidants as novel neuroprotective agents. Molecules15:7792-7814.
16. Lee JM, Robson MD, Yu LM, Shirodaria CC, Cunnington C, Kylintireas I, Digby JE, Bannister T, Handa A, Wiesmann F, Durrington PN, Channon KM, Neubauer S, Choudhury RP (2009) Effects of high-dose modified-release nicotinic acid on atherosclerosis and vascular function: a randomized, placebo-controlled, magnetic resonance imaging study. J Am Coll Cardiol54:1787-1794.
17. Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med329:2002-2012.
18. Morano S, Gatti A, Mandosi E, Tiberti C, Fallarino M, Cipriani R, Buchetti B, Gandini L, Sgro P, Jannini EA, Lenti L, Lenzi A (2007a) Circulating monocyte oxidative activity is increased in patients with type 2 diabetes and erectile dysfunction. J Urol177:655-659.
19. Morano S, Mandosi E, Fallarino M, Gatti A, Tiberti C, Sensi M, Gandini L, Buchetti B, Lenti L, Jannini EA, Lenzi A (2007b) Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo controlled study. Eur Urol52:1768-1774.
20. NIH Consensus Conference. (1993) Impotence. NIH Consensus Development Panel on Impotence. JAMA270:83-90.
21. Orlandi A, Marcellini M, Pesce D, Calvani M, Spagnoli LG (2002) Propionyl- l-carnitine reduces intimal hyperplasia after injury in normocholesterolemic rabbit carotid artery by modulating proliferation and caspase 3-dependent apoptosis of vascular smooth muscle cells. Atherosclerosis160:81-89.
22. Rendell MS, Rajfer J, Wicker PA, Smith MD (1999) Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA281:421-426.
23. Triggiani M, Oriente A, Golino P, Gentile M, Battaglia C, Brevetti G, Marone G (1999) Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-l-carnitine. Biochem Pharmacol58:1341-1348.